Transcriptomics

Dataset Information

0

Faecalibaterium prausnitzii strain EXL01 boosts efficacy of Immune Checkpoint Inhibitors


ABSTRACT: Gut microbiota impacts responses to immune checkpoint inhibitors (ICI). High level of Faecalibacterium prausnitzii has been associated with a positive response to ICI in multiple cancer types. Here, we show in two independent cohorts of patients with non-small cell lung cancer and advanced melanoma that high level of F. prausnitzii at baseline is positively associated with a better clinical response to ICI. In a mouse preclinical model, we show that the F. prausnitzii strain EXL01, already in clinical development for Inflammatory Bowel Disease, restores the anti-tumor response to ICI in the context of antibiotic-induced microbiota perturbation at clinical and tumor transcriptomics level. In vitro, EXL01 strain enhances T cell activation in the presence of ICI. Interestingly, oral administration of EXL01 strain is not associated with a change in fecal microbiota diversity or composition suggesting a direct effect on immune cells in the small intestine.

ORGANISM(S): Mus musculus

PROVIDER: GSE234818 | GEO | 2024/07/10

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-11-02 | GSE72048 | GEO
2023-08-11 | GSE224881 | GEO
2021-01-08 | E-MTAB-9387 | biostudies-arrayexpress
| PRJNA413728 | ENA
| PRJNA933642 | ENA
2021-03-06 | GSE168352 | GEO
| PRJNA930465 | ENA
| PRJNA74643 | ENA
| PRJNA1101570 | ENA
| PRJNA757920 | ENA